dolutegravir sodium tablet for oral suspension film-coated tablet
dolutegravir sodium - film-coated tablet - dolutegravir sodium tablet for oral suspension - dolutegravir
dolutegravir, lamivudine and tenofovir disoproxil tablet
lupin limited 3rd floor, kalpataru inspire, off w. e. highway, - dolutegravir, lamivudine and tenofovir disoproxil - tablet - dolutegravir, lamivudine and tenofovir disoproxil - dolutegravir
dolutegravir 50 mg, lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg tablet oral tablet dolutegravir 50mg, lamivudine 300mg and tenofovir disoproxil fumerate 300mg
macleods pharmaceuticals limited, india - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - oral tablet - dolutegravir 50mg, lamivudine 300mg and tenofovir disoproxil fumerate 300mg
dolutegravir tablets 50mg
dolutegravir sodium. - tablet - : each film coated tablet contains: dolutegravir - dolutegravir
dolutegravir (as sodium) , lamivudine and film-coated tablet
cipla limited cipla house, peninsula business park, ganpatrao - dolutegravir (as sodium) , lamivudine and - film-coated tablet - dolutegravir (as sodium): 50 mg , lamivudine: 300 - lamivudine and tenofovir disoproxil
dolutegravir sodium, lamivudine and tenofovir tablet
cipla quality chemical industries limited plot 1 - 7, 1st ring road, luzira industrial - dolutegravir sodium, lamivudine and tenofovir - tablet - dolutegravir sodium 50mg, lamivudine 300mg and - direct acting antivirals
dolutegravir, lamivudine and tenofovir disoproxil film-coated tablet
laurus labs limited 2nd floor, serene chambers, road no.-7 banjara - dolutegravir, lamivudine and tenofovir disoproxil - film-coated tablet - dolutegravir 50mg, lamivudine 300mg and tenofovir - antivirals for systemic use
dolutegravir, emtricitabine and tenofovir film-coated tablet
dolutegravir, emtricitabine and tenofovir - film-coated tablet - dolutegravir, emtricitabine and tenofovir - antivirals for systemic use: combinations of
juluca- dolutegravir sodium and rilpivirine hydrochloride tablet, film coated
viiv healthcare company - dolutegravir sodium (unii: 1q1v9v5wyq) (dolutegravir - unii:dko1w9h7m1), rilpivirine hydrochloride (unii: 212wax8kdd) (rilpivirine - unii:fi96a8x663) - dolutegravir 50 mg - juluca is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (hiv-1 rna less than 50 copies per ml) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of juluca. juluca is contraindicated in patients: • with previous hypersensitivity reaction to dolutegravir or rilpivirine [see warnings and precautions (5.1)] . • receiving dofetilide due to the potential for increased dofetilide plasma concentrations and the risk for serious and/or life-threatening events [see drug interactions (7)] . • receiving other coadministered drugs in table 1 that significantly decrease rilpivirine plasma concentrations [see drug interactions (7), clinical pharmacology (12.3)] . drug class contraindicated drugs in class clinical comment antia
dolutegravir and lamivudine 50/300 mg tablet
cipla limited cipla house, peninsula business park, ganpatrao - dolutegravir sodium and lamivudine - tablet - 50 mg of dolutegravir (equivalent to 52.6 mg - antivirals for systemic use: combinations of